News | August 03, 2025
FDA restrict 7-OH opioid products to protect consumers
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Additional data will be presented on a once-weekly oral combination of islatravir and ulonivirine (ISL/ULO) for HIV-1 treatment
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of Ovarian Cancer, AIDS-Related Kaposi's Sarcoma, and Multiple Myeloma
Extended lab space for product development, customer demos, and training
Subscribe To Our Newsletter & Stay Updated
